Table IV.
Comparison of ABPM and eGFR in stages and IAT period
| Variable | Control group (n = 11) | EH group (n=18) | Value of p EH group | ||
|---|---|---|---|---|---|
| S-0 | IAT | S-1 | |||
| SBP [mmHg] | 117.5±8.3 | 135.0**±12.3 | 125.5*±8.5 | 131.3*±9.8 | S-0 : S-1 – NS |
| S-0 : IAT –<0.05 | |||||
| P-1 : IAT –<0.05 | |||||
| DBP [mmHg] | 69.9±5.3 | 85.0**±11.5 | 77.4*±7.0 | 81.7**±8.5 | S-0 : S-1 – NS |
| NS S-0 : IAT –<0.05 | |||||
| S-1 : IAT –<0.05 | |||||
| eGFR [ml/min] | 116.4±21.4 | 121.0±38.0 | – | 138.7±39.7 | S-0 : S-1 –<0.001 |
S-0 – stage 0, S-1 – stage 1, IAT – period of intensive antihypertensive treatment, *significance level vs. the control group:
*for p < 0.05
**for p < 0.001, NS – non-significant